ASSOCIATION OF Α-TNF AND IRON PARAMETERS IN ANEMIC AND NON-ANEMIC PTB

Main Article Content

Dr Priti Yadav
Dr Sadhna Ajay
Dr Farhat Fatima
Dr. Ashish Agarwal

Keywords

Anemia, Pulmonary tuberculosis, α-tumor necrosis factor, Iron, ferritin

Abstract

Background: Tuberculosis has been major killer globally since the centuries and has now become a tenth leading cause of death worldwide. It is an air-borne chaos that induces systemic inflammation and have commonly linked with different comorbid clinical condition such as anemia. In chronic diseases such as pulmonary tuberculosis (PTB), inflammation due to bacterial burden play a vital role in Patho-physiology of anaemia.


Methodology: A comparative type of case control study. The study included 40 newly diagnosed anemic PTB (cases) and 40 newly diagnosed non anemic PTB (controls) of either gender having age group of 20-70 years. The PTB was confirmed by microscopic examination of sputum specimen for the detection of Acid-Fast Bacilli (AFB). Serum iron was analyzed by ferrozine method and α-TNF were analyzed by ELISA method. SPSS 20 version were used for the statistical analysis.


Results: Significantly higher levels of α-TNF (225.77±77.49) were observed in anemic PTB cases than that of non-anemic PTB cases (p<0.001). Significantly inverse correlation was observed between α-TNF and iron(p<0.05) and positive association between α-TNF and Ferritin (p<0.05) in both the groups.


Conclusion: Increased α-TNF leads to higher bacterial burden and lower iron levels.

Abstract 96 | Pdf Downloads 78

References

1. World Health Organization. Global tuberculosis report 2017. Geneva: WHO; 2017. Available.
2. Bhat H, Ambekar JG, Harwalkar AK, Dongre N, Das KK. Role of TNF-α on the Function of Erythropoietin and Hematological Profile in Pulmonary Tuberculosis Patients. Journal of Clinical & Diagnostic Research. 2018;12(8).
3. TBAnnaulReport2020.https://tbcindia.gov.in/showfile.php?lid=3538.
4. Hunter RL. Tuberculosis as a three-act play: A new paradigm for the pathogenesis of pulmonary tuberculosis. Tuberculosis. 2016; 97:8-17.
5. Dye C. Global epidemiology of tuberculosis. The Lancet. 2006;367(9514):938-40.
6. Rohini K, Bhat MS, Srikumar P, Kumar AM. Assessment of hematological parameters in pulmonary tuberculosis patients. Indian Journal of Clinical Biochemistry. 2016;31(3):332- 5.
7. Jurado RI. Iron, infection, and anaemia of inflammation. Clin Infect Dis. 1997;25: 888–895.
8. Isanaka S, Mugusi F, Urassa W, Willett WC, Bosch RJ, Villamor E, et al. Iron deficiency and anemia predict mortality in patients with tuberculosis. J Nutr. 2012;142(2):350-7. http://dx.doi.org/10.3945/ jn.111.144287
9. Oliveira MG, Delogo KN, Oliveira HM, Ruffino-Netto A, Kritski AL, Oliveira MM. Anemia in hospitalized patients with pulmonary tuberculosis. Jornal Brasileiro de Pneumologia. 2014;40(4):403-10.
10. Garner P, Smith H, Munro S, Volmink J. Promoting adherence to tuberculosis treatment. Bulletin of the World Health Organization. 2007;85:404-6.
11. Lee SW, Kang YA, Yoon YS, Um SW, Lee SM, Yoo CG, et.al. The prevalence and evolution of anemia associated with tuberculosis. Journal of Korean medical science. 2006;21(6):1028-32.
12. Andrade Júnior DR, Santos SA, Castro ID, Andrade DR. Correlation between serum tumor necrosis factor alpha levels and clinical severity of tuberculosis. Brazilian Journal of Infectious Diseases. 2008;12(3):226-33.
13. DeMaeyer EA, Adiels-Tegman M. The prevalence of anaemia in the world. World health statistics quarterly 1985; 38 (3): 302-316.
14. Chakraborty A. Epidemiology of tuberculosis: current status in India. Indian journal of medical research. 2004;120(4):248.
15. Flynn JL and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol 2001; 19:93-129.
16. Lombard EH &Mansvelt EP (1993) Haematological changes associated with milliary tuberculosis of bone marrow. Tuber Lung Dis 74, 131–135.
17. Baynes RD, Flax H, Bothwell TH, et al. (1986a) Haematological and iron related measurements in active pulmonary tuberculosis. Scand J Haematol 36, 280–287.
18. Kulkarni R, Deshpande A, Saxena K, Sinha AR, Verma M, Saxena R. Role of Tumor necrosis factor alpha, Malondialdehyde& serum Iron in Anemic Tuberculosis Patients. Biomed Res. 2011 Jan 1;22(1):69-72.
19. Kaminskaia GO, AbdullaevRIu. Iron metabolism in patients with different variants of pulmonary tuberculo-sis ProblTuberk. 2002; 12: 49-51
20. Kaminskaia GO, AbdullaevRIu, Baturova GA, et al. The specific features of iron intake in patients treated for pulmonary tuberculosis ProblTuberkBoleznLegk. 2009; 7: 46-55
21. Bruno CM, Neri S, Sciacca C, Bertino G, Di Prima P, Cilio D, Pellicano R, Caruso L, Cristaldi R. Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases. World journal of gastroenterology. 2004 May 1;10(9):1353.
22. Kulkarni RA, Deshpande AR, Saxena K. Interplay of serum erythropoietin and inflammatory cytokine in anemic tuberculosis patients. National Journal of Community Medicine. 2015; 6(4).
23. Przybyszewska J, Zekanowska E, Kedziora-Kornatowska K, Boinska J, Cichon R, Porzych K. Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron deficiency anemia. Pol Arch Med Wewn. 2013 Jan 1;123(3):105-1.
24. Feelders RA, Vreugdenhil G, Eggermont AM, et al. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferring receptors in cancer patients. Eur J Clin Invest. 1998; 28: 520-527
25. Cairo G, Recalcati S, Pietrangelo A, et al. The iron reg-ulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med. 2002; 32: 1237-1243.